High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Becquart, Pierre ^a,b   Wauquier, Nadia ^a   Mahlakõiv, Tanel ^a   Nkoghe, Dieudonné ^a   Padilla, Cindy ^a   Souris, Marc ^b,c   Ollomo, Benjamin ^a   Gonzalez, Jean Paul ^a   De Lamballerie, Xavier ^b   Kazanji, Mirdad ^a   Leroy, Eric M ^a,b  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b Aix Marseille University IRD 190 Inserm 1207   (France)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; EBOLA VIRUS; ECOSYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GABON; GRASSLAND; HEALTH SURVEY; HUMAN; HUMORAL IMMUNITY; LAKE ECOSYSTEM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; RISK FACTOR; RURAL POPULATION; SAVANNA; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; VIRUS INFECTION; WESTERN BLOTTING; ZAIRE EBOLAVIRUS; ZAIRE EBOLAVIRUS INFECTION; AGE; BLOOD; EBOLA HEMORRHAGIC FEVER; EPIDEMIOLOGY; GEOGRAPHY; IMMUNOLOGY; INFANT; METABOLISM; MIDDLE AGED; PREVALENCE; STATISTICS; T LYMPHOCYTE; VIROLOGY;

ZAIRE EBOLAVIRUS;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; GEOGRAPHY; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INFANT; INTERFERON-GAMMA; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 77949407840     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009126     Document Type: Article

References (58)

1. Sanchez A, Geisbert TW, Feldmann H (2007) Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams and Williams. pp 1409-1448.
2. Feldmann H, Geisbert TW, Jahrling PB, Klenk HD, Netesov SV, et al. (2005) Filoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. Virus taxonomy: VIIIth report of the international committee on taxonomy of viruses. London, United Kingdom: Elsevier Academic Press. pp 645-653.
3. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, et al. (1990) Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335: 502-505.
4. Rollin PE, Williams RJ, Bressler DS, Pearson S, Cottingham M, et al. (1999) Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 179: S108-S114.
5. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, et al. (2009) Discovery of swine as a host for the Reston ebolavirus. Science 325: 204-206.
6. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, et al. (1995) Isolation and partial characterisation of a new strain of Ebola. The Lancet 345: 1271-1274.
7. Smith DIH (1978) Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ 56: 247-270.
8. Baron RC, McCormick JB, Zubeir OA (1983) Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61: 997-1003.
9. World Health Organization (2004) Ebola haemorrhagic fever in south Sudan - update. Wkly Epidemiol Rec 79: 253.
10. Centers for Disease Control (2001) Ebola outbreak in Uganda. Morb Mortal Wkly Rep 50: 73-77.
11. Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, et al. (2002) An outbreak of Ebola in Uganda. Trop Med Int Health 7: 1068-1075.
12. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. (2008) Newly discovered ebola virus associated with hemorrhagic Fever outbreak in Uganda. PLoS Pathog 4: e1000212.
13. Johnson KM (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56: 271-293.
14. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, et al. (1999) The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 179: S76-S86.
15. Georges AJ, Leroy EM, Renaut AA, Tevi Benissan C, Nabias RJ, et al. (1999) Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: Epidemiologic and Health control issues. J Infect Dis 179: S65-S75.
16. Leroy EM, Rouquet P, Formenty P, Souquière S, Kilbourne A, et al. (2004) Multiple Ebola virus transmission events and rapid decline of central african wildlife. Science 303: 387-390.
17. Wittmann TJ, Biek R, Hassanin A, Rouquet P, Reed P, et al. (2007) Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proc Natl Acad Sci U S A 104: 17123-17127.
18. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, et al. (2005) Fruit bats as reservoirs of Ebola virus. Nature 438: 575-576.
19. Pourrut X, Delicat A, Rollin PE, Ksiazek TG, Gonzalez JP, et al. (2007) Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis 196 Suppl 2: S176-183.
20. Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, et al. (2007) Marburg virus infection detected in a common African bat. PLoS ONE 2: e764.
21. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, et al. (2007) Studies of reservoir hosts for Marburg virus. Emerg Infect Dis 13: 1847-1851.
22. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, et al. (2009) Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5: e1000536.
23. Walsh PD, Abernethy KA, Bermejo M, Beyers R, De Wachter P, et al. (2003) Catastrophic ape decline in western equatorial Africa. Nature 422: 611-614.
24. Bermejo M, Rodriguez-Teijeiro JD, Illera G, Barroso A, Vila C, et al. (2006) Ebola outbreak killed 5000 gorillas. Science 314: 1564.
25. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, et al. (2009) Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 6: 723-728.
26. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355: 2210-2215.
27. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ (1999) ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 179: S192-198.
28. Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, et al. (1999) Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 179: S102-S107.
29. Gonzalez JP, Nakoune E, Slenczka W, Vidal P, Morvan JM (2000) Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect 2: 39-44.
30. Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges AJ, et al. (1982) Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Trans R Soc Trop Med Hyg 76: 719-720.
31. Bouree P, Bergmann JF (1983) Ebola virus infection in man: a serological and epidemiological survey in the cameroons. Am J Trop Med Hyg 32: 1465-1466.
32. Gonzalez JP, Josse R, Johnson ED, Merlin M, Georges AJ, et al. (1989) Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. Res Virol 140: 319-331.
33. Johnson BK, Wambui C, Ocheng D, Gichogo A, Oogo S, et al. (1986) Seasonal variation in antibodies against Ebola virus in Kenyan fever patients. Lancet 1: 1160.
34. Johnson ED, Gonzalez JP, Georges AJ (1993) Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans Roy Soc Trop Med Hyg 87: 536-538.
35. Heffernan RT, Pambo B, Hatchett RJ, Leman PA, Swanepoel R, et al. (2005) Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. J Infect Dis 191: 964-968.
36. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, et al. (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nature Med 5: 1-5.
37. Lanzavecchia A, Sallusto F (2000) Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290: 92-97.
38. Masopust D, Vezys V, Marzo AL, Lefrancois L (2001) Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
39. Brehm MA, Selin LK, Welsh RM (2004) CD8 T cell responses to viral infections in sequence. Cell Microbiol 6: 411-421.
40. Kaech SM, Wherry EJ (2007) Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27: 393-405.
41. Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
42. Gourley TS, Wherry EJ, Masopust D, Ahmed R (2004) Generation and maintenance of immunological memory. Semin Immunol 16: 323-333.
43. Amanna IJ, Slifka MK, Crotty S (2006) Immunity and immunological memory following smallpox vaccination. Immunol Rev 211: 320-337.
44. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. (2003) Duration of antiviral immunity after smallpox vaccination. Nat Med 9: 1131-1137.
45. Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, et al. (2004) Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 199: 1585-1593.
46. Wilson JA, Hart MK (2001) Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral Nucleoprotein. J Virol 75: 2660-2664.
47. Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang Z-Y, et al. (2003) Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424: 681-684.
48. Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, et al. (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11: 786-790.
49. Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, et al. (2005) Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J Immunol 175: 1184-1191.
50. Olinger GG, Bailey MA, Dye JM, Bakken R, Kuehne A, et al. (2005) Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J Virol 79: 14189-14196.
51. Richardson JS, Yao MK, Tran KN, Croyle MA, Strong JE, et al. (2009) Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS One 4: e5308.
52. Qiu X, Fernando L, Alimonti JB, Melito PL, Feldmann F, et al. (2009) Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One 4: e5547.
53. Kingdom J (1984) East african mammals, Edition UoCP. Chicago: University of Chigaco Press.
54. van Stipdonk MJ, Lemmens EE, Schoenberger SP (2001) Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2: 423-429.
55. Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, et al. (2002) Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 4: 145-151.
56. Field H, Young P, Yob JM, Mills J, Hall L, et al. (2001) The natural history of Hendra and Nipah viruses. Microbes Infect 3: 307-314.
57. Collectif (2004) Grands ensembles végétaux du Gabon. Atlas du Gabon, Jaguar Léd, eds. Paris. 76 p.
58. Moe JB, Lambert RD, Lupton HW (1981) Plaque assay for Ebola virus. J Clin Microbiol 13: 791-793.